Skip to main content
Fig. 4 | European Journal of Hybrid Imaging

Fig. 4

From: Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis

Fig. 4

Kaplan–Meier survival probability curves for the primary end-point of major adverse cardiac events (MACE) demonstrate that patients with late gadolinium enhancement (LGE), focal FDG uptake, and co-localized focal FDG uptake and LGE have worse event-free survival compared to patients without those findings. The number of patients at risk is shown at the bottom of the figures. Annualized event rates were higher in patients with LGE, focal FDG uptake, and co-localized focal FDG uptake and LGE

Back to article page